KALEIDO BIOSCIENCES INC's ticker is KLDO and the CUSIP is 483347100. A total of 45 filers reported holding KALEIDO BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $31,000 | -96.2% | 500,500 | 0.0% | 0.00% | -94.3% |
| Q1 2022 | $826,000 | -30.9% | 500,500 | 0.0% | 0.04% | +9.4% |
| Q4 2021 | $1,196,000 | -56.2% | 500,500 | 0.0% | 0.03% | -47.5% |
| Q3 2021 | $2,733,000 | -26.6% | 500,500 | 0.0% | 0.06% | -19.7% |
| Q2 2021 | $3,724,000 | -8.1% | 500,500 | 0.0% | 0.08% | +5.6% |
| Q1 2021 | $4,054,000 | -11.0% | 500,500 | 0.0% | 0.07% | -26.5% |
| Q4 2020 | $4,555,000 | -17.8% | 500,500 | 0.0% | 0.10% | -27.4% |
| Q3 2020 | $5,541,000 | +49.0% | 500,500 | 0.0% | 0.14% | +29.8% |
| Q2 2020 | $3,719,000 | +20.8% | 500,500 | 0.0% | 0.10% | -20.0% |
| Q1 2020 | $3,078,000 | +22.5% | 500,500 | 0.0% | 0.13% | +34.0% |
| Q4 2019 | $2,513,000 | -62.9% | 500,500 | -44.4% | 0.10% | -64.3% |
| Q3 2019 | $6,781,000 | -35.1% | 900,500 | 0.0% | 0.27% | -35.5% |
| Q2 2019 | $10,446,000 | -24.0% | 900,500 | -5.0% | 0.42% | -24.8% |
| Q1 2019 | $13,737,000 | – | 947,419 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 1,920,027 | $23,435,000 | 8.67% |
| Flagship Pioneering Inc. | 19,360,710 | $214,323,000 | 5.92% |
| Palo Alto Investors LP | 786,400 | $8,705,000 | 0.48% |
| Artal Group S.A. | 500,500 | $5,541,000 | 0.14% |
| BAINCO INTERNATIONAL INVESTORS | 14,500 | $161,000 | 0.02% |
| FEDERATED HERMES, INC. | 500,000 | $5,535,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 17,855 | $198,000 | 0.01% |
| MARTINGALE ASSET MANAGEMENT L P | 31,108 | $345,000 | 0.00% |
| FMR LLC | 3,151,259 | $34,884,000 | 0.00% |
| Squarepoint Ops LLC | 24,088 | $267,000 | 0.00% |